Pubblicazioni Scientifiche
Dermatologia23 giu 2025
European Guideline (EuroGuiDerm) on atopic eczema
The evidence- and consensus-based living guideline on atopic eczema
23 giu 2025
Off-Label Use of Topical Ruxolitinib in Dermatology
JAK inhibitors are used to treat various inflammatory skin disease
23 giu 2025
A clinical-dermoscopic risk scoring model for early melanoma of the soles
Melanoma of the sole is an aggressive rare form, often diagnosed late
04 giu 2025
International expert consensus recommendations for the use of dermocosmetics
Dermocosmetics can improve tolerability and enhance result
04 giu 2025
Evaluating the Efficacy of Bimekizumab Across Different Sensitive Areas
Efficacy of bimekizumab in bio-naive and bio-experienced patients with moderate-to-severe psoriasis
04 giu 2025
European S2k guidelines
Second part of the S2k guidelines
20 mag 2025
Reduced liver disease incidence in psoriasis patients
Reduced liver disease incidence in psoriasis patients treated with interleukin-23 inhibitors
20 mag 2025
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients
Our study aimed to evaluate which clinical and psychological factors may impact treatment satisfaction in psoriatic patients
20 mag 2025
Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib
Ritlecitinib and baricitinib are recently approved systemic treatments for severe alopecia areata
30 apr 2025
Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients
Pustular psoriasis (PP) is a rare life-threatening skin disease with negatively impact on quality of life
30 apr 2025
Survival after cessation of immunotherapies in melanoma
Immune-checkpoint inhibitor (ICI) therapy elicits durable responses in a subset of patients with advanced melanoma
30 apr 2025
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis
An international, real-world comparative study
14 apr 2025
Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia
Literature about trichoscopy of permanent chemotherapy-induced alopecia
14 apr 2025
Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors
Limited data exist on the comparative risk of infections during biologic and Janus kinase inhibitor (JAKi) treatment for atopic dermatitis (AD) in daily practice
14 apr 2025
Passive versus active educational interventions for nevus and melanoma classification
Patients or family members first notice around 50% of primary melanoma lesions
26 mar 2025
Grover's disease in oncologic patients
Clinicopathologic features and systematic review
26 mar 2025
Neoadjuvant Immunotherapy in Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (cSCC) is the second most common type
26 mar 2025
Diagnosis and treatment of dermatofibrosarcoma protuberans
Dermatofibrosarcoma protuberans (DFSP) is a cutaneous fibroblastic tumour that is locally aggressive
05 mar 2025
Hormonal Therapies for Acne
Acne impairs quality of life, often leads to permanent scars, and causes psychological distress
05 mar 2025
Atopic dermatitis
Atopic dermatitis is the most common chronic inflammatory skin disease globally